VTGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.96%

Insider Buying (Last 12 Months): $17,958,751.40

Insider Selling (Last 12 Months): $0.00

Vistagen Therapeutics Insider Trading History Chart

Vistagen Therapeutics Share Price & Price History

^$4.72

▼ -0.11 (-2.28%)

As of 04/24/2024 01:00 AM ET

Days: 30 | 90 | 365

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

Vistagen Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/7/2023	Commodore Capital Lp	Major Shareholder	Buy	775,756	$23.15	$17,958,751.40	1,575,000
8/18/2022	Jerry B Gin	Director	Buy	3,333	$5.40	$17,998.20	3,333
8/17/2022	Reid G Adler	Insider	Buy	10,000	$5.10	$51,000.00	11,154
8/17/2022	Shawn Singh	CEO	Buy	20,000	$5.10	$102,000.00	20,874
7/12/2022	Venrock Healthcare Capital Par	Major Shareholder	Sell	2,000	$26.70	$53,400.00	687,909
9/7/2021	Jerrold Duane Dotson	CFO	Sell	1,000	$93.60	$93,600.00	2,426
8/17/2021	H. Ralph Snodgrass	Insider	Buy	125	$81.90	$10,237.50

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

SEC Filings (Institutional Ownership Changes) for Vistagen Therapeutics (NASDAQ:VTGN)

78.39% of Vistagen Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vistagen Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/15/2024	Great Point Partners LLC	1,858,735	$9.55M	1.6%	N/A	6.879%
2/15/2024	BVF Inc. IL	2,000,000	$10.28M	0.3%	N/A	7.402%
2/14/2024	ADAR1 Capital Management LLC	245,502	$1.26M	0.5%	N/A	0.909%
2/14/2024	AdvisorShares Investments LLC	54,311	$0.28M	0.1%	N/A	0.201%
2/13/2024	Tower Research Capital LLC TRC	9,298	$48K	0.0%	N/A	0.034%
2/13/2024	Armistice Capital LLC	478,000	$2.46M	0.0%	N/A	1.769%
1/30/2024	BML Capital Management LLC	150,000	$0.77M	0.6%	+50.0%	0.555%
11/14/2023	Schonfeld Strategic Advisors LLC	138,500	$0.73M	0.0%	N/A	1.480%
11/9/2023	Blair William & Co. IL	85,173	$0.45M	0.0%	N/A	0.910%
10/24/2023	Raymond James & Associates	10,000	$52K	0.0%	N/A	0.107%
10/23/2023	BML Capital Management LLC	100,000	$0.52M	0.5%	N/A	1.068%
4/13/2023	Allspring Global Investments Holdings LLC	212,443	$26K	0.0%	N/A	0.097%
4/11/2023	Henrickson Nauta Wealth Advisors Inc.	200,000	$25K	0.0%	N/A	0.091%
2/13/2023	GSA Capital Partners LLP	5,095,354	$0.53M	0.1%	-2.4%	2.323%
2/9/2023	MAI Capital Management	617,733	$64K	0.0%	-66.7%	0.299%
1/27/2023	GPS Wealth Strategies Group LLC	253,205	$25K	0.0%	+3,444.8%	0.122%
11/7/2022	Virtu Financial LLC	230,742	$35K	0.0%	N/A	0.112%
8/16/2022	Commodore Capital LP	13,049,079	$11.48M	2.4%	+29.2%	6.309%
8/15/2022	Acuta Capital Partners LLC	11,361,451	$10M	5.6%	-3.2%	5.498%
8/12/2022	Dorsey & Whitney Trust CO LLC	150,000	$0.13M	0.0%	+100.0%	0.073%
8/12/2022	Franklin Resources Inc.	9,448,954	$8.32M	0.0%	-4.9%	4.573%
7/29/2022	Oak Family Advisors LLC	390,742	$0.34M	0.2%	+93.7%	0.189%
7/29/2022	SG Americas Securities LLC	29,443	$26K	0.0%	-75.3%	0.014%
7/27/2022	Assenagon Asset Management S.A.	360,475	$0.32M	0.0%	N/A	0.174%
7/20/2022	Exchange Traded Concepts LLC	29,136	$26K	0.0%	+337.9%	0.014%
7/19/2022	MAI Capital Management	2,661,398	$2.34M	0.0%	N/A	1.288%
7/7/2022	Epiq Partners LLC	1,301,350	$1.15M	0.7%	+12.1%	0.630%
5/16/2022	Ghost Tree Capital LLC	1,315,154	$1.63M	0.4%	-34.2%	0.637%
5/11/2022	Dorsey & Whitney Trust CO LLC	75,000	$93K	0.0%	+275.0%	0.036%
5/11/2022	GSA Capital Partners LLP	73,969	$92K	0.0%	N/A	0.036%
5/10/2022	Nicholas Investment Partners LP	4,570,387	$5.67M	0.4%	+6.6%	2.213%
5/4/2022	ClariVest Asset Management LLC	252,700	$0.31M	0.0%	-12.3%	0.122%
5/3/2022	Oak Family Advisors LLC	201,727	$0.25M	0.1%	+9.3%	0.098%
4/29/2022	SG Americas Securities LLC	119,157	$0.15M	0.0%	+194.5%	0.058%
4/29/2022	Nisa Investment Advisors LLC	80,000	$99K	0.0%	N/A	0.039%
4/27/2022	Epiq Partners LLC	1,161,350	$1.44M	0.8%	+15.9%	0.562%
2/15/2022	Commodore Capital LP	8,464,999	$16.51M	3.8%	+65.2%	4.239%
2/14/2022	Parallax Volatility Advisers L.P.	94,941	$0.19M	0.0%	N/A	0.048%
2/11/2022	Eagle Asset Management Inc.	14,723	$30K	0.0%	N/A	0.007%
2/10/2022	Rafferty Asset Management LLC	490,295	$0.96M	0.0%	+98.8%	0.246%
2/9/2022	Principal Financial Group Inc.	149,035	$0.29M	0.0%	+299.9%	0.075%
2/8/2022	ProShare Advisors LLC	42,391	$82K	0.0%	+70.8%	0.021%
2/8/2022	Northern Trust Corp	1,954,286	$3.81M	0.0%	-2.2%	0.979%
2/7/2022	SG Americas Securities LLC	40,460	$79K	0.0%	-46.7%	0.020%
2/3/2022	Advisor Group Holdings Inc.	42,696	$83K	0.0%	+45.0%	0.021%
2/2/2022	New York State Common Retirement Fund	367,052	$0.72M	0.0%	+173.6%	0.184%
2/2/2022	Oak Family Advisors LLC	184,517	$0.36M	0.1%	+4.7%	0.092%
1/31/2022	CWM LLC	13,500	$26K	0.0%	N/A	0.007%
1/25/2022	Epiq Partners LLC	1,002,350	$1.96M	1.0%	+9.4%	0.502%
11/16/2021	Schonfeld Strategic Advisors LLC	422,500	$1.16M	0.0%	-31.1%	0.212%
11/16/2021	Two Sigma Advisers LP	1,109,500	$3.04M	0.0%	+75.8%	0.575%
11/16/2021	Two Sigma Investments LP	1,118,684	$3.07M	0.0%	-5.9%	0.580%
11/16/2021	Commodore Capital LP	5,123,509	$14.04M	3.7%	+53.8%	2.656%
11/15/2021	California State Teachers Retirement System	103,192	$0.28M	0.0%	-60.9%	0.053%
11/15/2021	Sphera Funds Management LTD.	3,824,938	$10.48M	0.9%	-6.3%	1.983%
11/15/2021	Zacks Investment Management	12,000	$33K	0.0%	N/A	0.006%
11/15/2021	HighVista Strategies LLC	438,239	$1.20M	0.8%	+42.2%	0.227%
11/15/2021	Franklin Resources Inc.	10,118,437	$27.73M	0.0%	+1.8%	5.245%
11/15/2021	GSA Capital Partners LLP	31,984	$88K	0.0%	N/A	0.017%
11/12/2021	The Manufacturers Life Insurance Company	103,727	$0.28M	0.0%	-6.1%	0.054%
11/12/2021	Geode Capital Management LLC	3,078,554	$8.44M	0.0%	+2.2%	1.596%
11/12/2021	EAM Global Investors LLC	634,743	$1.74M	0.4%	N/A	0.329%
11/12/2021	EAM Investors LLC	842,545	$2.31M	0.4%	+114.7%	0.437%
11/12/2021	E Fund Management Co. Ltd.	13,783	$38K	0.0%	N/A	0.007%
11/10/2021	Goldman Sachs Group Inc.	1,624,246	$4.45M	0.0%	+177.7%	0.842%
11/10/2021	Citigroup Inc.	175,052	$0.48M	0.0%	+1,822.4%	0.091%
11/10/2021	Rafferty Asset Management LLC	246,683	$0.68M	0.0%	N/A	0.128%
11/9/2021	Barclays PLC	79,396	$0.22M	0.0%	+228.0%	0.041%
11/9/2021	BlackRock Inc.	11,748,472	$32.19M	0.0%	+0.8%	6.090%
11/9/2021	Principal Financial Group Inc.	37,270	$0.10M	0.0%	+27.6%	0.019%
11/8/2021	Mackenzie Financial Corp	11,230	$31K	0.0%	N/A	0.006%
11/5/2021	Advisor Group Holdings Inc.	29,441	$81K	0.0%	+110.7%	0.015%
11/4/2021	Exencial Wealth Advisors LLC	98,731	$0.27M	0.0%	-22.2%	0.051%
11/4/2021	Deutsche Bank AG	118,795	$0.33M	0.0%	-36.3%	0.062%
11/4/2021	Financial Advocates Investment Management	23,097	$63K	0.0%	N/A	0.012%
11/2/2021	New York State Common Retirement Fund	134,173	$0.37M	0.0%	-18.1%	0.070%
11/2/2021	Victory Capital Management Inc.	795,720	$2.18M	0.0%	+76.9%	0.412%
11/1/2021	SG Americas Securities LLC	75,925	$0.21M	0.0%	N/A	0.039%
11/1/2021	Twin Lakes Capital Management LLC	94,500	$0.26M	0.2%	N/A	0.049%
10/19/2021	Epiq Partners LLC	916,100	$2.51M	1.2%	-1.8%	0.475%
10/14/2021	Genesee Capital Advisors LLC	19,860	$54K	0.0%	N/A	0.010%
9/3/2021	Parametric Portfolio Associates LLC	12,064	$38K	0.0%	N/A	0.006%
8/18/2021	Ikarian Capital LLC	916,552	$2.89M	0.2%	-68.2%	0.475%
8/17/2021	Samsara BioCapital LLC	732,596	$2.31M	0.3%	-60.0%	0.381%
8/17/2021	Beacon Pointe Advisors LLC	19,080	$60K	0.0%	N/A	0.010%
8/17/2021	Sphera Funds Management LTD.	4,080,673	$12.85M	0.9%	-2.3%	2.124%
8/17/2021	Metropolitan Life Insurance Co NY	64,386	$0.20M	0.0%	N/A	0.034%
8/17/2021	MetLife Investment Management LLC	84,097	$0.27M	0.0%	N/A	0.044%
8/17/2021	Price T Rowe Associates Inc. MD	56,771	$0.18M	0.0%	+43.7%	0.030%
8/17/2021	Prudential Financial Inc.	12,530	$39K	0.0%	N/A	0.007%
8/17/2021	Acuta Capital Partners LLC	11,728,033	$36.94M	14.8%	-4.6%	6.105%
8/17/2021	Boothbay Fund Management LLC	127,418	$0.40M	0.0%	-57.6%	0.066%
8/16/2021	AQR Capital Management LLC	109,703	$0.35M	0.0%	N/A	0.057%
8/16/2021	Amalgamated Bank	34,628	$0.11M	0.0%	N/A	0.018%
8/16/2021	California State Teachers Retirement System	264,181	$0.83M	0.0%	N/A	0.138%
8/16/2021	Commodore Capital LP	3,331,315	$10.49M	3.6%	-10.7%	1.734%
8/16/2021	Schonfeld Strategic Advisors LLC	613,600	$1.93M	0.0%	+127.4%	0.319%
8/16/2021	Charles Schwab Investment Management Inc.	474,361	$1.50M	0.0%	+853.0%	0.247%
8/16/2021	State Street Corp	3,059,610	$9.64M	0.0%	N/A	1.593%
8/16/2021	Nuveen Asset Management LLC	686,380	$2.16M	0.0%	N/A	0.357%

Data available starting January 2016

Vistagen Therapeutics, Inc., a late clinical-stage biopharmaceutical company, primarily focus to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders. The company's pipeline includes six clinical stage product candidates, including five investigational agents belonging to drugs known as pherines. Its product pipeline comprises PH94B, a fasedienol nasal spray, which is in Phase III development for the treatment of social anxiety disorder; and PH10, a Ituvone nasal spray which is in Phase II development for the treatment of major depressive disorder. In addition, the company is also developing PH15, an early-stage investigational synthetic neuroactive steroid for the treatment of cognition improvement; PH80, an odorless and tasteless synthetic investigational pherine for the treatment of menopausal hot flashes and migraine; PH284, an early-stage investigational synthetic neuroactive steroid for the treatment of wasting syndrome Cachexia; and AV-101, an oral nmdr glycine site antagonist for depression and neurological disorders. Further, it has a license and collaboration agreement with EverInsight Therapeutics Inc. to develop and commercialize to address ophthalmologic and CNS disorders. The company was founded in 1998 and is headquartered in South San Francisco, California.

Today's Range

Now: $4.72

$4.65

$4.86

50 Day Range

MA: $4.78

$3.92

$5.42

52 Week Range

Now: $4.72

$1.62

$24.71

Volume

147,550 shs

Average Volume

279,852 shs

Market Capitalization

$127.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.77

Who are the company insiders with the largest holdings of Vistagen Therapeutics?: Vistagen Therapeutics' top insider shareholders include:
Commodore Capital Lp (Major Shareholder)
Venrock Healthcare Capital Par (Major Shareholder)
Shawn Singh (CEO)
Reid G Adler (Insider)
Jerry B Gin (Director)
Learn More about top insider investors at Vistagen Therapeutics.